![Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II](https://i1.rgstatic.net/ii/profile.image/1030451405799426-1622690168564_Q128/Marco-Castellana.jpg)
Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II
![Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II](https://www.researchgate.net/profile/Apostolos-Tsapas/publication/325120706/figure/fig1/AS:657305355972608@1533725217312/Weighted-mean-difference-in-change-in-HbA1c-Semaglutide-vs-placebo-Abbreviations_Q320.jpg)
Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II
![Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II](https://i1.rgstatic.net/ii/profile.image/273857995079680-1442304242776_Q128/Aris-Liakos.jpg)
Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II
![Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II](https://i1.rgstatic.net/ii/profile.image/277634169753616-1443204552878_Q128/Philippos-Klonizakis-2.jpg)
Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II
![Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis - Avgerinos - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis - Avgerinos - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/399f1877-b1c2-4264-9010-26f3be927878/dom13899-fig-0001-m.jpg)
Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis - Avgerinos - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II Ioannis AVGERINOS | MD MSc | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Department of Internal Medicine II](https://i1.rgstatic.net/ii/profile.image/943667116257280-1601999181513_Q64/Georgios-Tousinas-2.jpg)